Abstract
Session presented on Monday, November 9, 2015 and Tuesday, November 10, 2015:
The purpose of this study is to disseminate current evidence on population genome health and related epigenetic factors, through the meta-analyses of methylenetetrahydrofolate reductase (MTHFR) gene in pregnant women who developed hypertension (PIH). PIH including preeclampsia are the leading causes of maternal and perinatal mortalities. Preeclampsia presents not only more severe form of PIH, but also additional dysfunctions including edema, proteinuria, headache, and impaired vision. Literatures were searched from various databases using a set of key words for the meta-analyses. Quality scores for the studies and inter-rater evaluation on data coding were completed to ensure data accuracy for pooled meta-analyses. Preliminary results included 6079 cases and 11061 controls from 53 studies. MTHFR 677 homozygous (TT) mutation genotype was significantly associated with increased risk of developing PIH (RR= 1.23, p < 0.01). Subgroup analyses revealed that MTHFR 677TT subtype was a significant risk of PIH in European (RR= 1.20, p < 0.01; 2478 cases and 6175 controls in 19 studies) and in Asian (RR= 1.56, p < 0.01, 1261 cases and 2238 controls in 13 studies). For lifestyle factors, body mass index (BMI) before pregnancy (Kg/M 2) was an important predictor for the development of PIH. Normal weight (BMI < 25) was protective against the development of PIH and preeclampsia (RR = 0.75, p < 0.0001); whereas, overweight (BMI = 25-29, RR = 1.52, p < 0.0001) and obesity (BMI > 30, RR = 1.80, p < 0.0001) were associated with increased risk of developing PIH and preeclampsia (376 cases and 2294 controls in 2 studies of Caucasian women). Future studies are needed to examine epigenetic factors associated with MTHFR gene mutations in the prevention PIH. Keywords: meta-analyses, epigenetics, pregnancy induced hypertension
Sigma Membership
Lambda Beta at-Large
Type
Poster
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Pregnancy Induced Hypertension, Epigenetics, Meta-Analyses
Recommended Citation
Yang, Ya-Ling and Shiao, Shyang-Yun Pamela K., "Gene mutations and pregnancy induced hypertension: A meta-analysis" (2016). Convention. 197.
https://www.sigmarepository.org/convention/2015/posters_2015/197
Conference Name
43rd Biennial Convention
Conference Host
Sigma Theta Tau International
Conference Location
Las Vegas, Nevada, USA
Conference Year
2015
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Review Type
Abstract Review Only: Reviewed by Event Host
Acquisition
Proxy-submission
Gene mutations and pregnancy induced hypertension: A meta-analysis
Las Vegas, Nevada, USA
Session presented on Monday, November 9, 2015 and Tuesday, November 10, 2015:
The purpose of this study is to disseminate current evidence on population genome health and related epigenetic factors, through the meta-analyses of methylenetetrahydrofolate reductase (MTHFR) gene in pregnant women who developed hypertension (PIH). PIH including preeclampsia are the leading causes of maternal and perinatal mortalities. Preeclampsia presents not only more severe form of PIH, but also additional dysfunctions including edema, proteinuria, headache, and impaired vision. Literatures were searched from various databases using a set of key words for the meta-analyses. Quality scores for the studies and inter-rater evaluation on data coding were completed to ensure data accuracy for pooled meta-analyses. Preliminary results included 6079 cases and 11061 controls from 53 studies. MTHFR 677 homozygous (TT) mutation genotype was significantly associated with increased risk of developing PIH (RR= 1.23, p < 0.01). Subgroup analyses revealed that MTHFR 677TT subtype was a significant risk of PIH in European (RR= 1.20, p < 0.01; 2478 cases and 6175 controls in 19 studies) and in Asian (RR= 1.56, p < 0.01, 1261 cases and 2238 controls in 13 studies). For lifestyle factors, body mass index (BMI) before pregnancy (Kg/M 2) was an important predictor for the development of PIH. Normal weight (BMI < 25) was protective against the development of PIH and preeclampsia (RR = 0.75, p < 0.0001); whereas, overweight (BMI = 25-29, RR = 1.52, p < 0.0001) and obesity (BMI > 30, RR = 1.80, p < 0.0001) were associated with increased risk of developing PIH and preeclampsia (376 cases and 2294 controls in 2 studies of Caucasian women). Future studies are needed to examine epigenetic factors associated with MTHFR gene mutations in the prevention PIH. Keywords: meta-analyses, epigenetics, pregnancy induced hypertension
Description
43rd Biennial Convention 2015 Theme: Serve Locally, Transform Regionally, Lead Globally.